It's a double knock-out! The quaking mouse is a spontaneous deletion of parkin and parkin co-regulated gene (PACRG)

被引:46
作者
Lockhart, PJ [1 ]
O'Farrell, CA [1 ]
Farrer, MJ [1 ]
机构
[1] Mayo Clin Jacksonville, Jacksonville, FL 32224 USA
关键词
Parkinson's disease; mouse model; parkin knockout; PACRG knockout;
D O I
10.1002/mds.20000
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in the parkin gene (PRKN) are the commonest cause of juvenile and early-onset parkinsonism. However, the pathogenic mechanism by which loss of parkin protein results in degeneration of dopaminergic neurons remains elusive. Animal models provide a useful tool for the study of development and disease, and the recent production of transgenic fly and mouse parkin deficient models allows investigation of the molecular role of parkin in dopamine regulation and nigrostriatal function. We have identified the mouse mutant Quaking as a spontaneously occurring PRKN knockout. The quaking mutation is a deletion of approximately 1.17 Mb of mouse chromosome 17, resulting in the deletion of the entire promoter and first five coding exons of PRKN In addition, the recently described Parkin Co-Regulated Gene (PACRG) is completely deleted. Homozygous Quaking mice show a complete loss of PRKN and PACRG mRNA and protein. These mice will constitute a useful additional model for studies of the molecular role of parkin and PACRG in neurodegeneration. (C) 2003 Movement Disorder Society.
引用
收藏
页码:101 / 104
页数:4
相关论文
共 18 条
[1]   MOLECULAR-BIOLOGY OF MYELIN PROTEINS FROM THE CENTRAL NERVOUS-SYSTEM [J].
CAMPAGNONI, AT .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (01) :1-14
[2]   Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene [J].
Cox, RD ;
Hugill, A ;
Shedlovsky, A ;
Noveroske, JK ;
Best, S ;
Justice, MJ ;
Lehrach, H ;
Dove, WF .
GENOMICS, 1999, 57 (03) :333-341
[3]  
EBERSOLE T, 1992, GENETICS, V131, P183
[4]   The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins [J].
Ebersole, TA ;
Chen, Q ;
Justice, MJ ;
Artzt, K .
NATURE GENETICS, 1996, 12 (03) :260-265
[5]   Parkin: A multipurpose neuroprotective agent? [J].
Feany, MB ;
Pallanck, LJ .
NEURON, 2003, 38 (01) :13-16
[6]   AGING AND PARKINSONS-DISEASE - SUBSTANTIA-NIGRA REGIONAL SELECTIVITY [J].
FEARNLEY, JM ;
LEES, AJ .
BRAIN, 1991, 114 :2283-2301
[7]   Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons [J].
Goldberg, MS ;
Fleming, SM ;
Palacino, JJ ;
Cepeda, C ;
Lam, HA ;
Bhatnagar, A ;
Meloni, EG ;
Wu, NP ;
Ackerson, LC ;
Klapstein, GJ ;
Gajendiran, M ;
Roth, BL ;
Chesselet, MF ;
Maidment, NT ;
Levine, MS ;
Shen, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :43628-43635
[8]   Genetics of parkinsonism [J].
Gwinn-Hardy, K .
MOVEMENT DISORDERS, 2002, 17 (04) :645-656
[9]  
Hardy RJ, 1996, J NEUROSCI, V16, P7941
[10]  
IMAI Y, IN PRESS J BIOL CHEM